Award
National Institute on Aging 1R01AG095167-01
A Type 2 Hybrid Effectiveness-Implementation Study of Time Limited Trials to Reduce Potentially Non-Beneficial Treatments for Critically Ill Patients with Advanced Medical Illnesses
Recipient
LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER
Awarded
September 24, 2025
Identifier
1R01AG095167-01
NIH grant awarded for a study aimed at reducing potentially non-beneficial treatments in critically ill patients through time-limited trials and communication strategies in Southern California healthcare systems.
Description
This is a NIH grant opportunity for a study on reducing low-value ICU care through communication strategies, involving a pragmatic hybrid effectiveness-implementation trial in diverse healthcare systems in Southern California.